143 related articles for article (PubMed ID: 19094130)
1. Intravenous immunoglobulin treatment in laryngeal pemphigoid.
Gürcan HM; Ahmed AR
Clin Exp Dermatol; 2009 Dec; 34(8):884-6. PubMed ID: 19094130
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
Sami N; Bhol KC; Razzaque Ahmed A
Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
[TBL] [Abstract][Full Text] [Related]
3. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
Galdos M; Etxebarría J
Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
[TBL] [Abstract][Full Text] [Related]
6. [Cicatricial mucous membrane pemphigoid with laryngeal involvement. Case report and review of the literature].
Wilhelm T
HNO; 1992 Dec; 40(12):495-9. PubMed ID: 1493972
[TBL] [Abstract][Full Text] [Related]
7. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
Daoud Y; Amin KG; Mohan K; Ahmed AR
Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
[TBL] [Abstract][Full Text] [Related]
8. Mucous membrane pemphigoid: nasal and laryngeal manifestations.
Whiteside OJ; Martinez Devesa P; Ali I; Capper JW
J Laryngol Otol; 2003 Nov; 117(11):885-8. PubMed ID: 14670151
[TBL] [Abstract][Full Text] [Related]
9. Current medical treatment of ocular mucous membrane pemphigoid.
Sobolewska B; Deuter C; Zierhut M
Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
Foster CS; Ahmed AR
Ophthalmology; 1999 Nov; 106(11):2136-43. PubMed ID: 10571350
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
14. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
Foster CS; Chang PY; Ahmed AR
Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
[TBL] [Abstract][Full Text] [Related]
15. The management of mucous membrane pemphigoid and pemphigus.
Knudson RM; Kalaaji AN; Bruce AJ
Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of mucous membrane pemphigoid and connective-tissue disease.
Malik M; Gürcan HM; Ahmed AR
Clin Exp Dermatol; 2010 Mar; 35(2):156-9. PubMed ID: 19438545
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine.
Gan DC; Welsh B; Webster M
Australas J Dermatol; 2012 Feb; 53(1):66-9. PubMed ID: 22309336
[TBL] [Abstract][Full Text] [Related]
18. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study.
Letko E; Bhol K; Foster SC; Ahmed RA
Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601
[TBL] [Abstract][Full Text] [Related]
19. Cicatricial pemphigoid with severe gingival and laryngeal involvement in an 18-year-old female.
Ojha J; Bhattacharyya I; Stewart C; Katz J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Sep; 104(3):363-7. PubMed ID: 17376714
[TBL] [Abstract][Full Text] [Related]
20. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Ahmed AR; Colón JE
Arch Dermatol; 2001 Sep; 137(9):1181-9. PubMed ID: 11559214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
